{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:48:57Z","timestamp":1788220137259,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clineuro.2025.109149","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:36:27Z","timestamp":1757140587000},"page":"109149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative efficacy and safety of tricyclic antidepressants vs. serotonin-norepinephrine reuptake inhibitors for migraine prophylaxis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"258","author":[{"given":"Sufyan","family":"Shahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9320-1228","authenticated-orcid":false,"given":"Minahil","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umna","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ibrahim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humza","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasiba","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeb","family":"Saifullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Marsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.109149_bib1","unstructured":"Pescador Ruschel M.A., De Jesus O. Migraine Headache. [Updated 2024 Jul 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560787\/."},{"issue":"17","key":"10.1016\/j.clineuro.2025.109149_bib2","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J. Neurosci. Official J. Soc. Neurosci."},{"issue":"23","key":"10.1016\/j.clineuro.2025.109149_bib3","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1111\/bph.15657","article-title":"Pharmacological treatment of migraine: drug classes, mechanisms of action, clinical trials and new treatments","volume":"178","author":"Zobdeh","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib4","first-page":"17","article-title":"Migraine headache prophylaxis","volume":"99","author":"Ha","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.clineuro.2025.109149_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108400","article-title":"Efficacy and safety of venlafaxine versus nortriptyline for the preventive treatment of migraine: a Double-Blind randomized clinical trial","volume":"243","author":"Roghani","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109149_bib6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/head.14135","article-title":"A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management","volume":"61","author":"Joshi","year":"2021","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109149_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000080960","article-title":"Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache","volume":"50","author":"Rampello","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.clineuro.2025.109149_bib8","unstructured":"Higgins, J.P.T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M.J., & Welch, V.A. (Eds.). (2024). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane."},{"key":"10.1016\/j.clineuro.2025.109149_bib9","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.clineuro.2025.109149_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4300\/JGME-D-22-00113.1","article-title":"Systematic reviews in medical education","volume":"14","author":"Maggio","year":"2022","journal-title":"J. Grad. Med. Educ."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clineuro.2004.03.004","article-title":"Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study","volume":"107","author":"Bulut","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clineuro.2025.109149_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107151","article-title":"Venlafaxine can reduce the migraine attacks as well as amitriptyline: a noninferiority randomized trial","volume":"214","author":"Hedayat","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109149_bib13","volume":"13","author":"Balda\u00e7ara","year":"2024","journal-title":"Tricyclic antidepressants update. Research Society Development"},{"key":"10.1016\/j.clineuro.2025.109149_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-019-0557-2","article-title":"Antidepressants for preventive treatment of migraine","volume":"21","author":"Burch","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1526-4610.2010.01800.x","article-title":"Amitriptyline in the prophylactic treatment of migraine and chronic daily headache","volume":"51","author":"Couch","year":"2011","journal-title":"Headache. J. Head. Face Pain."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10194-023-01573-6","article-title":"European headache federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention\u2014part 1: amitriptyline","volume":"24","author":"Lampl","year":"2023","journal-title":"J. Headache Pain."},{"issue":"15","key":"10.1016\/j.clineuro.2025.109149_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1080\/14656566.2023.2242264","article-title":"Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder","volume":"24","author":"Fagiolini","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109149_bib18","article-title":"Leki przeciwdepresyne typu SNRI: medycyna oparta na faktach I do\u015bwiadczeniu","volume":"19","author":"Szulc","year":"2022","journal-title":"Psychiatry\/Psychiatr."},{"key":"10.1016\/j.clineuro.2025.109149_bib19","first-page":"145","article-title":"Serotonin and norepinephrine reuptake inhibitors","author":"Shelton","year":"2019","journal-title":"Antidepressants Biog. Amines N. Mech. Action"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109149_bib20","first-page":"193","article-title":"Cost-effectiveness of venlafaxine for the treatment of depression and anxiety","volume":"34","author":"Baldomero","year":"2006","journal-title":"Actas Espa\u00f1olas De. Psiquiatr\u00eda"},{"issue":"11","key":"10.1016\/j.clineuro.2025.109149_bib21","first-page":"S386","article-title":"The pharmacoeconomics of venlafaxine in depression","volume":"7","author":"Morrow","year":"2001","journal-title":"Am. J. Manag Care"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/YIC.0b013e32834ce13f","article-title":"Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies","volume":"27","author":"de Silva","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109149_bib23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0269881108089821","article-title":"Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis","volume":"23","author":"Van Den Broek","year":"2009","journal-title":"J. Psychopharmacol."},{"issue":"17","key":"10.1016\/j.clineuro.2025.109149_bib24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American academy of neurology and the American headache society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib25","first-page":"1","article-title":"The American headache society position statement on integrating new migraine treatments into clinical practice. headache: the journal of head and face","volume":"59","author":"American Headache Society","year":"2019","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109149_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/2514183X18823377","article-title":"Treatment of migraine attacks and prevention of migraine: guidelines by the German migraine and headache society and the German society of neurology","volume":"3","author":"Diener","year":"2019","journal-title":"Clin. Transl. Neurosci."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725004329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725004329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T12:11:41Z","timestamp":1760789501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725004329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"alternative-id":["S0303846725004329"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109149","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of tricyclic antidepressants vs. serotonin-norepinephrine reuptake inhibitors for migraine prophylaxis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109149"}}